Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients: A meta-analysis

Clinical Radiology

Volumn 70, Issue 9, 2015, Pages 999-1008

  Duan, X ^a   Li, J ^a   Zhang, Q ^a   Zeng, Z ^a   Luo, Y ^a   Jiang, J ^a   Chen, Y ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

ADVERSE OUTCOME; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; FAINTNESS; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; IMAGE ENHANCEMENT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; CARDIOMYOPATHY, DILATED; DIAGNOSTIC USE; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT;

CARDIOMYOPATHY, DILATED; CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; PROGNOSIS; RISK ASSESSMENT;

EID: 84938289747     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2015.05.007     Document Type: Article

References (29)

1. J.L. Jefferies, and J.A. Towbin Dilated cardiomyopathy Lancet 375 2010 752 762
2. N. de Leeuw, D.J. Ruiter, A.H. Balk, and et al. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy Transpl Int 14 2001 299 306
3. P.J. Richardson Assessment of myocardial damage in dilated cardiomyopathy Eur Heart J 17 1996 489 490
4. K. Soejima, W.G. Stevenson, J.L. Sapp, and et al. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars J Am Coll Cardiol 43 2004 1834 1842
5. E. Delacretaz, W.G. Stevenson, K.E. Ellison, and et al. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischaemic heart disease J Cardiovasc Electrophysiol 11 2000 11 17
6. Z. Blanck, A. Dhala, S. Deshpande, and et al. Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients J Cardiovasc Electrophysiol 4 1993 253 262
7. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, and et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College Of Cardiology Foundation/American Heart Association Task Force On Practice Guidelines And The Heart Rhythm Society J Am Coll Cardiol 61 2013 e6 e75
8. A.M. Russo, R.F. Stainback, S.R. Bailey, and et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College Of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society Of Echocardiography, Heart Failure Society Of America, Society For Cardiovascular Angiography And Interventions, Society Of Cardiovascular Computed Tomography, And Society For Cardiovascular Magnetic Resonance Heart Rhythm 10 2013 e11 58
9. W.H. Maisel, M. Moynahan, B.D. Zuckerman, and et al. Pacemaker and ICD generator malfunctions: analysis of food and drug administration annual reports JAMA 295 2006 1901 1906
10. J.J. Germano, M. Reynolds, V. Essebag, and et al. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 97 2006 1255 1261
11. R. Tung, P. Zimetbaum, and M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
12. D. Bansch, M. Antz, S. Boczor, and et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT) Circulation 105 2002 1453 1458
13. D.J. Pennell Cardiovascular magnetic resonance Circulation 121 2010 692 705
14. J.C. Moon, M. Sheppard, E. Reed, and et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease J Cardiovasc Magn Reson 8 2006 479 482
15. R.G. Assomull, S.K. Prasad, J. Lyne, and et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
16. F. Leyva, R.J. Taylor, P.W. Foley, and et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy J Am Coll Cardiol 60 2012 1659 1667
17. A. Gulati, A. Jabbour, T.F. Ismail, and et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy JAMA 309 2013 896 908
18. T.G. Neilan, O.R. Coelho-Filho, S.B. Danik, and et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy JACC Cardiovasc Imaging 6 2013 944 954
19. M.P. Marra, M.D. Lazzari, A. Zorzi, and et al. Impact of presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy Heart Rhythm 14 2014 014
20. J.L. Looi, C. Edwards, G.P. Armstrong, and et al. Characteristics and prognostic importance of myocardial fibrosis in patients with dilated cardiomyopathy assessed by contrast-enhanced cardiac magnetic resonance imaging Clin Med Insights Cardiol 4 2010 129 134
21. M. Machii, H. Satoh, K. Shiraki, and et al. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome Magn Reson Imaging 32 2014 118 124
22. H.A. Rockman, C. Juneau, K. Chatterjee, and et al. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease Am J Cardiol 64 1989 1344 1348
23. GA Wells BS, D O'Connell, J Peterson, V Welch, M Losos, P Tugwell. Ottawa hospital research institution. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: Http://www.Ohri.Ca/programs/clinical-epidemiology/oxford.Asp. [accessed 04.03.14].
24. P. Gao, R. Yee, L. Gula, and et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging Circ Cardiovasc Imaging 5 2012 448 456
25. K.C. Wu, R.G. Weiss, D.R. Thiemann, and et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421
26. I. Shimizu, N. Iguchi, H. Watanabe, and et al. Delayed enhancement cardiovascular magnetic resonance as a novel technique to predict cardiac events in dilated cardiomyopathy patients Int J Cardiol 142 2010 224 229
27. P.G. Masci, A. Barison, G.D. Aquaro, and et al. Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy Int J Cardiol 157 2012 43 47
28. S. Lehrke, D. Lossnitzer, M. Schob, and et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy Heart 97 2011 727 732
29. A.K. Kono, K. Ishii, H. Kumagai, and et al. Late gadolinium enhancement on cardiac magnetic resonance imaging: is it associated with a higher incidence of nonsustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy? Jpn J Radiol 28 2010 355 361